Acquired NF2 mutation confers resistance to TRK inhibition in an ex vivo LMNA::NTRK1-rearranged soft-tissue sarcoma cell modelJOURNAL OF PATHOLOGYIF5.22024-04-121OA
Ex vivo modeling of acquired drug resistance in BRAF - mutated pancreatic cancer organoids uncovers individual therapeutic vulnerabilitiesCANCER LETTERSIF10.12024-03-011OA
Establishment and functional testing of a novel ex vivo extraskeletal osteosarcoma cell model (USZ20-ESOS1)HUMAN CELLIF3.12023-11-111OAAI
Addressing Modern Diagnostic Pathology for Patient-Derived Soft Tissue Sarcosphere Models in the Era of Functional Precision OncologyLABORATORY INVESTIGATIONIF4.22023-04-014OAAI
Unravelling homologous recombination repair deficiency and therapeutic opportunities in soft tissue and bone sarcoma揭开软组织和骨肉瘤的同源重组修复缺陷和治疗机会EMBO MOLECULAR MEDICINEIF8.32023-02-138OAAI
Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic NeoplasmsMODERN PATHOLOGYIF5.52022-12-018OAAI